Is JPM a buy, hold, or sell?
JPM carries a valuation grade of Buy. The trailing P/E of 14.8 sits broadly in line with the Financials sector median of 14.0x. Our discounted cash flow model produces an intrinsic range of $294–$419 — implying a +14% margin of safety at the current price of $312.70. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
The company has beaten estimates in 60% of recent quarters. The most recent quarter delivered a 7.8% earnings surprise. Analyst estimate revisions are trending upward.
What are JPM's key risk factors?
With a beta of 1.00, JPM exhibits a market-neutral risk profile relative to the broad market. The 95th-percentile CVaR of -9.1% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 0.9% of total portfolio loss in the worst 5% of months. Net margins of 33.9% are significantly above the Financials sector average of 28%, reflecting durable pricing power. Return on equity of 16.5% suggests solid capital efficiency.
At 0.00, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 2.7% is below realized volatility of 21.8%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $445.5M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 1.1% of float, suggesting limited bearish conviction.
How does JPM fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — JPM carries a beta of 1.00, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all buyings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, JPM shows the strongest co-movement with BAC (0.74), C (0.71), WFC (0.67). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.74, adding JPM to a portfolio that already buys these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all buyings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The JPM analysis here is a single node in that larger structure.
For our full conviction hierarchy across alternative asset managers — including JPM's positioning in the 2026 private credit stress test — see: Private Equity 2026: $265B Crisis — Why Blackstone & KKR Lead. For the BDC redemption mechanics and fund-level data underpinning these ratings: Private Credit 2026: BDC Liquidity Crisis & Systemic Stress Test →
